Blockchain Registration Transaction Record

Mayo Clinic's Dr. Howe to Discuss Aditxt's ADI-100 Study

Aditxt (NASDAQ: ADTX) reveals key findings from ADI-100 preclinical study with Mayo Clinic's Dr. Howe. Learn about the company's focus on accelerating health innovations and developing disruptive solutions for societal challenges.

Mayo Clinic's Dr. Howe to Discuss Aditxt's ADI-100 Study

This news matters as it showcases the collaboration between Aditxt and Mayo Clinic in advancing immune modulation therapy and developing innovative health solutions. Investors and stakeholders can gain insights into the latest findings in preclinical studies, demonstrating the company's commitment to addressing critical health challenges.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x96f51ba68119e6bbd33c22e518b8bac3309f9ff0847997d27ad0d158f1802758
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintevenk6js-81970c90d62068fb986edb544cfeff08